Immunological modulation by 1α,25-dihydroxyvitamin D 3 in patients with squamous cell carcinoma of the head and neck

Cytokine

Volumn 58, Issue 3, 2012, Pages 448-454

  Walker, David D ^a   Reeves, Travis D ^a   de Costa, Anna Maria ^a   Schuyler, Corinne ^b   Young, M Rita I ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Cytokines; Head and neck cancer; HNSCC; Vitamin D

Indexed keywords

CALCITRIOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER SURGERY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG DOSE SEQUENCE; DRUG EFFECT; DRUG MECHANISM; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; SQUAMOUS CELL CARCINOMA; TH1 CELL; TH2 CELL; TISSUE LEVEL; UPREGULATION;

CALCITRIOL; CARCINOMA, SQUAMOUS CELL; CYTOKINES; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 84860343623     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.002     Document Type: Article

References (28)

1. Parkin D., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Leemans C.R., Tiwari R., Nauta J.J.P., Waal I.V.D., Snow G.B. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994, 73:187-190.
3. Jones A., Morar P., Phillips D., Field J., Husband D., Helliwell T. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995, 75:1343-1353.
4. Rengarajan J., Szabo S.J., Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000, 21:479-483.
5. Ardestani S., Inserra P., Solkoff D., Watson R.R. The role of cytokines and chemokines on tumor progression: a review. Cancer Detect Prev 1999, 23:215-225.
6. Goto S., Sato M., Kaneko R., Itoh M., Sato S., Takeuchi S. Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunol Immunother 1999, 48:435-442.
7. Young M.R.I. Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 2004, 53:375-382.
8. Pries R., Wollenberg B. Cytokines in head and neck cancer. Cytokine Growth Factor Rev 2006, 17:141-146.
9. Gasparoto T.H., de Souza Malaspina T.S., Benevides L., de Melo E.J., Costa M.R. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Cancer Immunol Immunother 2010, 59:819-828.
10. Jebreel A., MIstry D., Loke D., Dunn G., Hough V., Aliver K., et al. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. J Laryngol Otol 2007, 121:246-252.
11. Wakita D., Chamoto K., Ohkuri T., Narita Y., Ashino S., Sumida K., et al. IFN-γ dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model. Carcinogenesis 2009, 30:1408-1415.
12. + progenitor cells into dendritic cells. Otolaryngol Head Neck Surg 2009, 140:235-240.
13. 3. Cancer Immunol Immunother 2004, 53:422-430.
14. + cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells. Int J Cancer 1997, 73:663-669.
15. + cells from the peripheral blood of head and neck cancer patients. J Leukoc Biol 1999, 65:623-628.
16. 3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Human Immunol 2010, 71:659-665.
17. 3) to inhibit carcinogenesis in the hamster buccal pouch model. Arch Otolaryngol Head Neck Surg 2007, 133:1149-1152.
18. Cantorna M.T., Yu S., Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med 2008, 29:369-375.
19. Chun R.F., Adams J.S., Hewison M. Back to the future: a new look at 'old' vitamin D. J Endocrinol 2008, 198:261-269.
20. 3 on intracellular IFN-γ and TNF-α positive T cell subsets in pulmonary tuberculosis. Cytokine 2009, 45:105-110.
21. 3 derivatives on type-1 cellular immunity. Biomed Res 2006, 27:1-9.
22. + cells increases the effectiveness of adoptive immunotherapy. J Immunother 2000, 23:115-124.
23. Muindi J.R., Peng Y., Potter D.R., Hershberger P.A., Tauch J.S., Capozzoli M.J., et al. Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clin Pharmacol Ther 2002, 72:648-659.
24. Salven P., Heikkila P., Anttonen A., Kajanti M., Joensuu H. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 1997, 10:1128-1133.
25. Sauter E.R., Nesbit M., Watson J.C., Klein-Szant K., Litwin S., Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 1999, 5:775-782.
26. Wolf J.S., Chen Z., Dong G., Sunwoo J.B., Bancroff C.C., Capo D.E., et al. IL (Interleukin)-1α promotes nuclear factor-κB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 2001, 7:1812-1820.
27. Vidal-Vanaclocha F., Fantuzzi G., Mendoza L., Fuentes A.M., Anasagasti M.J., Carrascal T., et al. IL-18 regulates IL-1β dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci USA 2000, 97:734-739.
28. Sparano A., Lathers D., Achille N., Petruzzelli G.J., Young M.R.I. Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2004, 131:573-576.